Skip to the main content

Psychiatria Danubina, Vol. 32 No. suppl. 1, 2020.

Conference paper

A BRAZILIAN CASE OF TREATMENT-RESISTANT GENERALIZED ANXIETY DISORDER SUCCESSFULLY TREATED WITH MONOAMINE OXIDASE INHIBITOR (MAOI)

Clara Gitahy Falcão Faria orcid id orcid.org/0000-0002-1290-2349 ; Laboratory of Panic and Respiration, Institute of Psychiatry, Federal University of Rio de Janeiro, School of Medicine, Rio de Janeiro, Brazil
Marcos Fidry orcid id orcid.org/0000-0002-8157-8562 ; Laboratory of Panic and Respiration, Institute of Psychiatry, Federal University of Rio de Janeiro, School of Medicine, Rio de Janeiro, Brazil
Mariana Costa do Cabo ; Laboratory of Panic and Respiration, Institute of Psychiatry, Federal University of Rio de Janeiro, School of Medicine, Rio de Janeiro, Brazil
Laiana Azevedo Quagliato ; Laboratory of Panic and Respiration, Institute of Psychiatry, Federal University of Rio de Janeiro, School of Medicine, Rio de Janeiro, Brazil
Antonio Egidio Nardi ; Laboratory of Panic and Respiration, Institute of Psychiatry, Federal University of Rio de Janeiro, School of Medicine, Rio de Janeiro, Brazil
Rashid Zaman ; Centre for Mental Health Research in association with University of Cambridge (CMHR-CU), Cambridge, UK; Hertfordshire Partnership University NHS Foundation Trust, Cambridge, UK; Department of Psychiatry, University of Cambridge, Cambridge, UK
Rafael Freire ; Laboratory of Panic and Respiration, Institute of Psychiatry, Federal University of Rio de Janeiro, School of Medicine, Rio de Janeiro, Brazil; Department of Psychiatry, School of Medicine, Queen’s University, Kingston, ON, Canada

Full text: english pdf 82 Kb

page 139-141

downloads: 386

cite

Abstract

In this brief report we present the case of a 53 year old man with a very debilitating Generalized Anxiety Disorder successfully
treated with tranylcypromine. After several failed treatment attempts following international guidelines recommendations over the course of one year and a half, tranylcypromine was prescribed which led to effective and sustained remission of anxiety symptoms for this patient. We also briefly explore treatment options for resistant cases of generalized anxiety disorder, given the major negative impacts of untreated GAD in a person's daily functioning and quality of life.

Keywords

Generalized Anxiety Disorder; treatment resistance cases; monoamine oxidase inhibitors

Hrčak ID:

262504

URI

https://hrcak.srce.hr/262504

Publication date:

24.3.2020.

Visits: 727 *